SINGAPORE (Apr 27): iX Biopharma has entered into a 10-year licensing agreement with Yiling Pharmaceutical in China for the licensing, supply, and distribution of Wafesil, a fast-dissolving sublingual sildenafil wafer for the treatment of male erectile dysfunction.
Have a premium account? Sign in to continue reading.
Unlimited access to all stories from $4.99/month*
The latest reporting and analysis from business and investments to news and views on social issues.
Bonus:
- Simultaneous logins across all devices
- Instant access to past digital issues
- Unlimited access to The Edge Malaysia
- *For annual subscription plan only. T&Cs apply
